Monday, July 28th21.2°C
22568

Sterigenics raises offer for Nordion to US$805 million or US$13 per share

OTTAWA - Medical isotope supplier Nordion Inc. (TSX:NDN) said Monday that Sterigenics has raised its takeover offer to US$805 million after an earlier offer failed to garner enough shareholder support.

The bid of $13 per share is up from $12.25 per share and the second increase to the offer, which began at $11.75.

Shareholders were to vote on the earlier offer last week, but the meeting was postponed after it became apparent the deal wouldn't receive the required two-thirds majority approval.

"Although a clear majority of Nordion shareholders supported Sterigenics’ all-cash acquisition proposal at US$12.25 per share, there did not appear to be sufficient shareholder support to approve the transaction," the company said in a statement.

Shareholders are expected to vote Friday on the new offer by Sterigenics, an affiliate of Chicago-based private equity firm GTCR LLC.

Nordion is a leading suppliers of medical isotopes, used for certain types of medical imaging. It also provides sterilization technologies for several industries.

The new offer follows an unsolicited offer of $12.50 last week from an unidentified third party that had earlier made an offer of US$12.25, Nordion said.

Nordion also reported Monday that it had a second-quarter profit of $6.7 million or 11 cents per share, up from a profit of $731,000 or a penny per share a year ago.

Revenue for the quarter ended April 30 totalled $74.7 million, up from $56.1 million in the same three months a year earlier.

On an adjusted basis, Nordion said it earned $13.5 million or 22 cents per share for the quarter, up from $4.8 million or eight cents per share in the second quarter last year.

The company settled a bitter legal fight with Atomic Energy of Canada Ltd. last year with a new supply deal that will run until October 2016 and an agreement by both sides to drop more than $100 million in claims.

A shortage of medical isotopes occurred around the world when AECL's NRU reactor was shut down in 2009 because of a leak that took more than a year to repair.

The shortage raised concerns about the availability of medical tests and Ottawa's decision to end the Maple program, an over-budget-and-behind-schedule plan to replace the NRU reactor.

The Canadian Press


Read more Business News




Recent Trending




Today's Market
S&P TSX15445.22-9.82
S&P CDNX1019.852.41
DJIA16982.5922.02
Nasdaq4444.909-4.655
S&P 5001978.91+0.57
CDN Dollar0.9251-0.001
Gold1305.20+2.10
Oil101.39-0.28
Lumber321.20-1.80
Natural Gas3.733-0.014

 
Okanagan Companies
Pacific Safety0.195+0.01
Knighthawk0.01-0.005
QHR Technologies Inc1.150.00
Cantex0.065-0.005
Anavex Life Sciences0.265-0.01
Metalex Ventures0.08+0.01
Russel Metals35.15-0.21
Copper Mountain Mining2.97+0.15
Colorado Resources0.225+0.015
ReliaBrand Inc0.10+0.019
Sunrise Resources Ltd0.02-0.03
Mission Ready Services0.19+0.01

 



22447

FEATURED Property
1917896Gardeners Delight!!
$364,900
more details
image2image2image2
Click here to feature your property
Please wait... loading


Take charge of your debt

Photo: Thinkstock.comWays to reduce your Debt:Make a budget and get budget counselingA basic first step for debt reduction is to prepare a budget and plan your spending. Once you have a budget, you mu...


Geopolitical tensions rattle markets

The Big Picture Geopolitical tensions rattle markets The spectre of rising geopolitical tensions in Ukraine and Gaza cast a shadow over an otherwise positive week in the markets. News that a passenger...


Learn to delegate effectively

Photo: ContributedI have the pleasure of witnessing people delegate tasks quite often. Sometimes with tremendous success and sometimes with disastrous consequences. I have chaired a lot of committees...

_








Member of BC Press Council


22707